2,267
Views
119
CrossRef citations to date
0
Altmetric
Review Article

Chitosan magnetic nanoparticles for drug delivery systems

, , , , , & show all
Pages 492-509 | Received 12 Oct 2015, Accepted 21 Feb 2016, Published online: 01 Jun 2016

References

  • Sun T, Zhang YS, Pang B, et al. Engineered nanoparticles for drug delivery in cancer therapy. Angew Chem Int Ed Engl. 2014;53:12320–12364.
  • Thomas CR, Ferris DP, Lee J-H, et al. Noninvasive remote-controlled release of drug molecules in vitro using magnetic actuation of mechanized nanoparticles. J Am Chem Soc. 2010;132:10623–10625.
  • Shagholani H, Ghoreishi SM, Mousazadeh M. Improvement of interaction between PVA and chitosan via magnetite nanoparticles for drug delivery application. Int J Biol Macromol. 2015;78:130–136.
  • Elias F, Christine V. Nanoparticles as drug delivery systems. In: Swarbrick J, editor. Encyclopedia of pharmaceutical science and technology. 4th ed. Taylor & Francis; 2013b.
  • Jafarizadeh-Malmiri H, Ghaz-Jahanian MA, Berenjian A. Potential applications of chitosan nanoparticles as novel support in enzyme immobolization. Am J Biochem Biotechnol. 2012;8:203–219.
  • Shaik MR, Korsapati M, Panati D. Polymers in controlled drug delivery systems. Int J Pharm Sci. 2012;2:112–116.
  • Elias F, Christine V. Drug delivery: nanoparticles. In: Swarbrick J, editor. Encyclopedia of pharmaceutical technology. 3rd ed. New York, USA: Taylor & Francis; 2013a.
  • Bucak S, Yavuztürk B, Sezer AD. Magnetic nanoparticles synthesis surface modifications and application in drug delivery. In: Sezer Ad, editor. Recent advances in novel drug carrier systems. Croatia: InTech; 2010. p. 165–200.
  • Cregg PJ, Murphy K, Mardinoglu A. Inclusion of interactions in mathematical modelling of implant assisted magnetic drug targeting. Appl Math Model. 2012;36:1–34.
  • Wilczewska AZ, Niemirowicz K, Markiewicz KH, et al. Nanoparticles as drug delivery systems. Nato Drugs. 2012;64:1020–1037.
  • Klostergaard J, Seeney CE. Magnetic nanovectors for drug delivery. Maturitas. 2012;73:33–44.
  • Wankhede M, Bouras A, Kaluzova M, et al. Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Rev Clin Pharmacol. 2012;5:173–186.
  • Cao Q, Han X, Li L. Enhancement of the efficiency of magnetic targeting for drug delivery: development and evaluation of magnet system. J Magn Magn Mater. 2011;323:1919–1924.
  • Nguyen TKT, Leduc T, Ian R. Biomedical applications: magnetic nanoparticles. In: Lyshevski SE, editor. Dekker encyclopedia of nanoscience and nanotechnology. 3rd ed. Taylor & Francis & CRC Press; 2014. p. 1740–1743.
  • Chandna A, Batra D, Kakar S, et al. A review on target drug delivery: magnetic microspheres. J Acute Dis. 2013;2:189–195.
  • Kakar S, Batra D, Singh R, et al. Magnetic microspheres as magical novel drug delivery system: a review. J Acute Dis. 2013;2:1–12.
  • Issa B, Obaidat IM, Albiss BA, et al. Magnetic nanoparticles: surface effects and properties related to biomedicine applications. Int J Mol Sci. 2013;14:21266–21305.
  • Zhou X, Porter AL, Robinson DKR, et al. Nano-enabled drug delivery: a research profile. Nanomedicine. 2014;10:889–896.
  • Khan DR. The use of nanocarriers for drug delivery in cancer therapy. J Cancer Sci Ther. 2010;2:58–62.
  • Mishra B, Patel BB, Tiwari S. Colloidal nanocarriers: a review on formulation technology, types and applications toward targeted drug delivery. Nanomedicine. 2010;6:9–24.
  • Unsoy G, Khodadust R, Yalcin S, et al. Synthesis of doxorubicin loaded magnetic chitosan nanoparticles for pH responsive targeted drug delivery. Eur J Pharm Sci. 2014;62:243–250.
  • Felton C, Karmakar A, Gartia Y, et al. Magnetic nanoparticles as contrast agents in biomedical imaging: recent advances in iron- and manganese-based magnetic nanoparticles. Drug Metab Rev. 2014;46:142–154.
  • Chen J-P, Yang P-C, Ma Y-H, et al. Characterization of chitosan magnetic nanoparticles for in situ delivery of tissue plasminogen activator. Carbohydr Polym. 2011;84:364–372.
  • Chomoucka J, Drbohlavova J, Huska D, et al. Magnetic nanoparticles and targeted drug delivering. Pharmacol Res. 2010;62:144–149.
  • Grüttner C, Müller K, Teller J, et al. Synthesis and functionalisation of magnetic nanoparticles for hyperthermia applications. Int J Hyperthermia. 2013;29:777–789.
  • Figuerola A, Di Corato R, Manna L, et al. From iron oxide nanoparticles towards advanced iron-based inorganic materials designed for biomedical applications. Pharmacol Res. 2010;62:126–143.
  • Obermeier A, Kuchler S, Matl FD, et al. Magnetic drug targeting as new therapeutic option for the treatment of biomaterial infections. J Biomater Sci Polym Ed. 2012;23:2321–2336.
  • Kim J-E, Shin J-Y, Cho M-H. Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects. Arch Toxicol. 2012;86:685–700.
  • Shah RR, Davis TP, Glover AL, et al. Impact of magnetic field parameters and iron oxide nanoparticle properties on heat generation for use in magnetic hyperthermia. J Magn Magn Mater. 2015;387:96–106.
  • Malhi S, Gu X. Nanocarrier-mediated drugs targeting cancer stem cells: an emerging delivery approach. Expert Opin Drug Deliv. 2015;12:1177–1201.
  • Ying X-Y, Du Y-Z, Hong L-H, et al. Magnetic lipid nanoparticles loading doxorubicin for intracellular delivery: preparation and characteristics. J Magn Magn Mater. 2011;323:1088–1093.
  • Sonam Chaudhary H, Arora V, Kholi K, et al. Effect of physicochemical properties of biodegradable polymers on nano drug delivery. Polym Rev. 2013;53:546–567.
  • Sultana S, Khan MR, Kumar M, et al. Nanoparticles-mediated drug delivery approaches for cancer targeting: a review. J Drug Target. 2013;21:107–125.
  • May JP, Li S-D. Hyperthermia induced drug targeting. Expert Opin Drug Deliv. 2013;10:511–527.
  • Fattahi H, Laurent S, Liu F, et al. Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. Nanomedicine (Lond). 2011;6:529–544.
  • Jana S, Sen KK, Basu SK. Chitosan derivatives and their application in pharmaceutical fields. Int J Pharm Res. 2011;3:1–8.
  • Prabaharan M. Chitosan-based nanoparticles for tumor-targeted drug delivery. Int J Biol Macromol. 2015;72:1313–1322.
  • Vaghari H, Jafarizadeh-Malmiri H, Berenjian A, et al. Recent advances in application of chitosan in fuel cells. Sustain Chem Process. 2013;1:1–12.
  • Najafi S, Pazhouhnia Z, Ahmadi O, et al. Chitosan nanoparticles and their applications in drug delivery: a review. Curr Res Drug Discov. 2014;1:17–25.
  • Assa F, Jafarizadeh-Malmiri H, Anarjan N, et al. Applications of chitosan nanoparticles in active biodegradable and sustainable food packaging. In: Durai Parbhakaran RT, Kale SA, Prabakar K, editors. Renewable energy and sustainable development. New York: Nova Science Publishers, Inc.; 2015. p. 227–244.
  • Pal K, Behera B, Roy S, et al. Chitosan based delivery systems on a length scale: nano to macro. Soft Mater. 2013;11:125–142.
  • Kraisit P, Limmatvapirat S, Nunthanid J, et al. Nanoparticle formation by using shellac and chitosan for a protein delivery system. Pharm Dev Technol. 2013;18:686–693.
  • Amirkhani L, Moghaddas J, Jafarizadeh-Malmiri H. Candida rugosa lipase immobilization on magnetic silica aerogel nanodispersion. RSC Adv. 2016;6:12676–12687.
  • Yang H-C, Hon M-H. The effect of the molecular weight of chitosan nanoparticles and its application on drug delivery. Microchem J. 2009;92:87–91.
  • Wang JJ, Zeng ZW, Xiao RZ, et al. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomedicine. 2011;6:765–774.
  • Kaushik A, Jayant RD, Sagar V, et al. The potential of magneto-electric nanocarriers for drug delivery. Expert Opin Drug Deliv. 2014;11:1635–1646.
  • Elmizadeh H, Khanmohammadi M, Ghasemi K, et al. Preparation and optimization of chitosan nanoparticles and magnetic chitosan nanoparticles as delivery systems using Box–Behnken statistical design. J Pharm Biomed Anal. 2013;80:141–146.
  • Reddy DHK, Lee S-M. Application of magnetic chitosan composites for the removal of toxic metal and dyes from aqueous solutions. Adv Colloid Interface Sci. 2013;201:68–93.
  • Kumari S, Singh RP. Glycolic acid functionalized chitosan–Au–Fe3O4 hybrid nanoparticle based nanohybrid scaffold for drug delivery. Int J Biol Macromol. 2013;54:244–249.
  • Honary S, Ebrahimi P, Rad HA, et al. Optimization of preparation of chitosan-coated iron oxide nanoparticles for biomedical applications by chemometrics approaches. Int Nano Lett. 2013;3:1–5.
  • Song X, Luo X, Zhang Q, et al. Preparation and characterization of biofunctionalized chitosan/Fe3O4 magnetic nanoparticles for application in liver magnetic resonance imaging. J Magn Magn Mater. 2015;388:116–122.
  • Grenha A. Chitosan nanoparticles: a survey of preparation methods. J Drug Target. 2012;20:291–300.
  • Chang Y, Xiao L. Preparation and characterization of a novel drug delivery system: biodegradable nanoparticles in thermosensitive chitosan/gelatin blend hydrogels. J Macromol Sci A. 2010;47:608–615.
  • Ghaz-Jahanian M, Abbaspour-Aghdam F, Anarjan N, et al. Application of chitosan-based nanocarriers in tumor-targeted drug delivery. Mol Biotechnol. 2015;57:201–218.
  • Castelló J, Gallardo M, Busquets MA, et al. Chitosan (or alginate)-coated iron oxide nanoparticles: a comparative study. Colloids Surf A. 2015;468:151–158.
  • Si H-Y, Li D-P, Wang T-M, et al. Improving the anti-tumor effect of genistein with a biocompatible superparamagnetic drug delivery system. J Nanosci Nanotechnol. 2010;10:2325–2331.
  • Shen J-M, Gao F-Y, Yin T, et al. cRGD-functionalized polymeric magnetic nanoparticles as a dual-drug delivery system for safe targeted cancer therapy. Pharmacol Res. 2013;70:102–115.
  • Ding Y, Shen SZ, Sun H, et al. Design and construction of polymerized-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery. Mater Sci Eng C Mater Biol Appl. 2015;48:487–498.
  • Kim J-E, Lim H-T, Minai-Tehrani A, et al. Toxicity and clearance of intratracheally administered multiwalled carbon nanotubes from murine lung. J Toxicol Environ Health A. 2010;73:1530–1543.
  • Sharma A, Madhunapantula SV, Robertson GP. Toxicological considerations when creating nanoparticle-based drugs and drug delivery systems. Expert Opin Drug Metab Toxicol. 2012;8:47–69.
  • Mahmoudi M, Simchi A, Imani M, et al. A new approach for the in vitro identification of the cytotoxicity of superparamagnetic iron oxide nanoparticles. Colloids Surf B Biointerfaces. 2010;75:300–309.
  • Upadhyaya L, Singh J, Agarwal V, et al. The implications of recent advances in carboxymethyl chitosan based targeted drug delivery and tissue engineering applications. J Control Release. 2014;186:54–87.
  • Yoo JW, Chambers E, Mitragotri S. Factors that control the circulation time of nanoparticles in blood: challenges, solutions and future prospects. Curr Pharm Des. 2010;16:2298–2307.
  • Reddy LH, Arias JL, Nicolas J, et al. Magnetic nanoparticles: design and characterization, toxicity and biocompatibility, pharmaceutical and biomedical applications. Chem Rev. 2012;112:5818–5878.
  • Araújo F, Shrestha N, Granja PL, et al. Safety and toxicity concerns of orally delivered nanoparticles as drug carriers. Expert Opin Drug Metab Toxicol. 2015;11:381–393.
  • Fang J-Y, Al-Suwayeh SA. Nanoparticles as delivery carriers for anticancer prodrugs. Expert Opin Drug Deliv. 2012;9:657–669.
  • Sunderland CJ, Steiert M, Talmadge JE, et al. Targeted nanoparticles for detecting and treating cancer. Drug Dev Res. 2006;67:70–93.
  • Morris J, Willis J. Nanotechnology white paper. Washington (DC): Agency UEP; 2007.
  • Javid A, Ahmadian S, Saboury AA, et al. Chitosan-coated superparamagnetic iron oxide nanoparticles for doxorubicin delivery: synthesis and anticancer effect against human ovarian cancer cells. Chem Biol Drug Des. 2013;82:296–306.
  • Vaghari H, Jafarizadeh-Malmiri H, Mohammadlou M, et al. Application of magnetic nanoparticles in smart enzyme immobilization. Biotech Lett. 2016;38:223–233.
  • Asmatulu R, Misak H, Yang S-Y, et al. Composite magnetic nanoparticle drug delivery system. United States patent application 20120265001; 2012.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.